The in vivo model supported this axis as well: in EL4 lymphoma-bearing mice, antibiotic treatment preserved near-normal filaggrin in tumour-adjacent epidermis. Together, the data support microbial-immune crosstalk as a mechanistic contributor to CTCL skin barrier pathology.
7/8
